Selective Therapeutic Intervention: A Challenge against Off-Target Effects.

Despite the massive global spend on biology-driven drug discovery, tackling the issue of side effects and adverse events resulting from drug promiscuity represents a persistent challenge. Although delivering authentic medical innovations today is more complex than ever, minimization of off-target effects should be a priority. [ABSTRACT FROM AUTHOR]